Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CTSO Cytosorbents Corp.
$6.41 0.63% +0.04
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CTSO stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 20.2M
Enterprise value 45.2M
Trailing PE -2.4980769230769
Forward PE -5.133571
PEG Ratio 0.00052407208176439
Enterprise to EBITDA -4.363
Enterprise to revenue 1.213
Price to book MRQ -27.159080332889
Price to sales TTM 0.5427385

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 37.2M
EBITDA -10349000
Diluted EPS TTM -5.8
Total Cash (MRQ) 4.4M
Current ratio (MRQ) 0.655
Operating Cash Flow (TTM) -9147000

CTSO trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CTSO News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.